SC Pharmaceuticals Inc (SCPH)
3.06 +0.05 (+1.66%) 11:56 ET [NASDAQ]
3.03 x 400 3.06 x 82
Realtime by (Cboe BZX)
3.03 x 400 3.06 x 82
Realtime - - (-) -
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select FieldsSymbol | SCPH | IVA | GLSI | ||
Company | SC Pharmaceuticals Inc | Inventiva S.A. ADR | Greenwich Lifesciences Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 2.97 | 2.82 | 11.16 | ||
High | 3.07 | 2.82 | 11.29 | ||
Low | 2.92 | 2.82 | 11.06 | ||
Last | 3.06 | 2.82 | 11.06 | ||
Change | +0.05 | -0.12 | -0.28 | ||
% Change | +1.66% | -4.08% | -2.47% | ||
Volume | 130,059 | 217 | 16,140 | ||
20-Day Average Volume | 592,471 | 10,561 | 22,759 | ||
Previous Close | 3.01 | 2.94 | 11.34 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | No | No | ||
Technicals | |||||
20-Day Moving Average | 3.12 | 2.98 | 11.75 | ||
20-Day Raw Stochastic | 38.96% | 25.07% | 3.96% | ||
20-Day Relative Strength | 43.98% | 51.20% | 40.10% | ||
Weighted Alpha | -38.68 | -26.77 | -39.43 | ||
Today's Opinion | 100% Sell | 88% Buy | 100% Sell | ||
Previous Opinion | 100% Sell | 88% Buy | 100% Sell | ||
Last Month's Opinion | 88% Sell | 24% Buy | 88% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +0.66% since 03/14/25 | -5.37% since 03/14/25 | -7.08% since 03/14/25 | ||
Low | 2.90 on 03/20/25 | 2.70 on 03/18/25 | 11.06 on 03/21/25 | ||
High | 3.19 on 03/20/25 | 3.08 on 03/20/25 | 13.33 on 03/17/25 | ||
1-Month | |||||
%Chg | -6.15% since 02/21/25 | -0.70% since 02/21/25 | -6.69% since 02/21/25 | ||
Low | 2.75 on 03/10/25 | 2.67 on 03/04/25 | 11.06 on 03/21/25 | ||
High | 3.52 on 03/03/25 | 3.27 on 02/27/25 | 13.33 on 03/17/25 | ||
3-Month | |||||
%Chg | -10.03% since 12/20/24 | +20.00% since 12/20/24 | -10.01% since 12/20/24 | ||
Low | 2.75 on 03/10/25 | 2.11 on 01/14/25 | 10.52 on 12/30/24 | ||
High | 3.87 on 02/13/25 | 3.27 on 02/27/25 | 14.47 on 01/07/25 | ||
6-Month | |||||
%Chg | -41.12% since 09/20/24 | +37.56% since 09/20/24 | -25.07% since 09/20/24 | ||
Low | 2.75 on 03/10/25 | 1.53 on 09/26/24 | 10.52 on 12/30/24 | ||
High | 5.23 on 09/23/24 | 3.27 on 02/27/25 | 15.50 on 09/25/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 150,620 | 154,282 | 149,064 | ||
Shares Outstanding, K | 50,040 | 52,477 | 13,145 | ||
Annual Sales | 13,590,000 | 25,070,000 | 0 | ||
Annual Net Income | -54,810,000 | -119,510,000 | -8,890,000 | ||
Last Quarter Sales | 10,030,000 | 65,000 | 0 | ||
Last Quarter Net Income | -35,110,000 | -14,296,000 | -2,670,000 | ||
60-Month Beta | 0.40 | 0.84 | 1.69 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.37 on 11/13/24 | N/A on 09/20/21 | -0.20 on 11/14/24 | ||
Latest Earnings Date | 05/13/25 | 03/26/25 | 04/21/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |